KALVISTA PHARMACEUTICALS LIMITED Patent Application Trends in 2024
KALVISTA PHARMACEUTICALS LIMITED Patent Filing Activity
KALVISTA PHARMACEUTICALS LIMITED patent applications in 2024
Error creating thumbnail: File missing
Top 10 Technology Areas
- A61K31/444 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 1 patents
- Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- A61K9/2054 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 1 patents
- Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- A61P7/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
- Count: 1 patents
- Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D401/02 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: [[20240199573. POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)]]
- C07B2200/13 (GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation)
- Count: 1 patents
- Example: [[20240199573. POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)]]
- C07D487/04 (Ortho-condensed systems)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D471/04 (Ortho-condensed systems)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D401/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D487/08 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
Emerging Technology Areas
- C07D471/08 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D487/08 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D401/12 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D471/04 (Ortho-condensed systems)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07D487/04 (Ortho-condensed systems)
- Count: 1 patents
- Example: 20240059691. ENZYME INHIBITORS simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- C07B2200/13 (GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation)
- Count: 1 patents
- Example: [[20240199573. POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)]]
- C07D401/02 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 1 patents
- Example: [[20240199573. POLYMORPHS OF N-[(3-FLUORO-4-METHOXYPYRIDIN-2-YL)METHYL]-3-(METHOXYMETHYL)-1-({4-[(2-OXOPYRIDIN-1-YL)METHYL]PHENYL}METHYL)PYRAZOLE-4-CARBOXAMIDE AND SALTS THEREOF simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)]]
- A61P7/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS)
- Count: 1 patents
- Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
- A61K9/2054 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 1 patents
- Example: 20240122909. TREATMENTS OF HEREDITARY ANGIOEDEMA simplified abstract (KALVISTA PHARMACEUTICALS LIMITED)
Top Inventors
Error creating thumbnail: File missing
- Hannah Joy EDWARDS (2 patents)
- Edward Paul FEENER of North Reading MA (US) (1 patent)
- Sally Louise MARSH (1 patent)
- Andreas MAETZEL of Chapel Hill NC (US) (1 patent)
- Michael David SMITH of Salt Lake City UT (US) (1 patent)
- Christopher Martyn YEA (1 patent)
- Haydn BEATON (1 patent)
- David Malcolm CROWE (1 patent)
- Mitchell Lewis CHILDS (1 patent)
- Rebecca Louise DAVIE (1 patent)
Patent Categories
Geographical Distribution of Inventors
Error creating thumbnail: File missing
Geographical Distribution of US Inventors
